Abstract: This chapter on the EU regulatory perspective of the intravenous
immunoglobulins (IVIGs) encompasses the following topics: – Regulatory framework for IVIGs; – Current EMEA initiatives: revision of the core SPC/IVIG Guideline; – Paediatric Regulation: impacts/outcomes; – Patient involvement and consultation in the EMEA activities.